Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline

F. Y. F. L. de Vos, H. W. M. van Laarhoven, J. S. E. Laven, A. P. N. Themmen, L. V. A. M. Beex, C. G. J. Sweep, C. Seynaeve, A. Jager

Research output: Contribution to JournalReview articleAcademicpeer-review

25 Citations (Scopus)


Breast cancer is the most common malignancy amongst women in the developed world. For patients with hormone-sensitive breast cancer eligible for adjuvant hormonal therapy, it is important to know if the ovaries are (still) functional or not. Indeed, the choice for a specific adjuvant hormonal treatment depends on the menopausal status of an individual woman. The currently available measures to determine the menopausal status are conflicting. Until better measures become available, we propose a practical guideline enabling an optimal choice of adjuvant hormonal therapy for women with a hormone receptor positive breast cancer taking into account uncertainties about their menopausal status. (C) 2012 Elsevier Ireland Ltd. All rights reserved
Original languageEnglish
Pages (from-to)252-260
JournalCritical reviews in oncology/hematology
Issue number2
Publication statusPublished - 2012

Cite this